The ibogaine medical subculture.

Ibogaine, a naturally occurring psychoactive alkaloid, is used within a global medical subculture to treat substance-related disorders, particularly opioid withdrawal. As of February 2006, an estimated 3,414 individuals had taken ibogaine—a fourfold increase from five years earlier—with 68% doing so for a substance-related disorder and 53% specifically for opioid withdrawal, the most common reason. The subculture lacks clinical and pharmaceutical standards, posing risks. Ethnographic analysis identified four types of ibogaine scenes: medical model, lay provider/treatment guide, activist/self-help, and religious/spiritual. The focus on opioid withdrawal distinguishes ibogaine from other psychedelics and aligns with experimental evidence of a significant pharmacologically mediated effect.

Study at a glance

Abstract

Ibogaine is a naturally occurring psychoactive indole alkaloid that is used to treat substance-related disorders in a global medical subculture, and is of interest as an ethnopharmacological prototype for experimental investigation and possible rational pharmaceutical development. The subculture is also significant for risks due to the lack of clinical and pharmaceutical standards. This study describes the ibogaine medical subculture and presents quantitative data regarding treatment and the purpose for which individuals have taken ibogaine. All identified ibogaine "scenes" (defined as a provider in an associated setting) apart from the Bwiti religion in Africa were studied with intensive interviewing, review of the grey literature including the Internet, and the systematic collection of quantitative data. Analysis of ethnographic data yielded a typology of ibogaine scenes, "medical model", "lay provider/treatment guide", "activist/self-help", and "religious/spiritual". An estimated 3414 individuals had taken ibogaine as of February 2006, a fourfold increase relative to 5 years earlier, with 68% of the total having taken it for the treatment of a substance-related disorder, and 53% specifically for opioid withdrawal. Opioid withdrawal is the most common reason for which individuals took ibogaine. The focus on opioid withdrawal in the ibogaine subculture distinguishes ibogaine from other agents commonly termed "psychedelics", and is consistent with experimental research and case series evidence indicating a significant pharmacologically mediated effect of ibogaine in opioid withdrawal.